Back to Skandinaviska Enskilda Banken AB (publ) Skandinaviska Enskilda Banken AB (publ)

KNTEKNTE
2 quarters

Position history for Skandinaviska Enskilda Banken AB (publ)Skandinaviska Enskilda Banken AB (publ)'s holdings in KINNATE BIOPHARMA INC

Skandinaviska Enskilda Banken AB (publ) previously held 0 shares of KNTE (KINNATE BIOPHARMA INC), worth $0 as of 2024-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$136,192

Total Shares Change

-51,200

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%
0
2024-Q1
New
51,200
-
$136,1920.0%
31

Other major holders of KNTE: RA CAPITAL MANAGEMENT, L.P., VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used